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The aim of this study was to provide data on genetic hazards associated with occupational exposure 
to low doses of ionising radiation in nuclear medicine departments. The DNA damage in peripheral 
blood lymphocytes of medical staff was assessed using the chromosome aberration test. Altogether 120 
subjects (60 exposed and 60 controls) participated in the study. The exposed subjects showed significantly 
higher frequencies of chromosome aberrations than controls. Significant inter-individual differences in 
DNA damage within the exposed population indicate different genome sensitivity. Age and sex were not 
confounding factors, while smoking increased DNA damage only in control subjects. This study suggests 
that chronic exposure to low doses of ionising radiation in nuclear medicine departments causes cytogenetic 
damage. For this reason, exposed medical personnel should minimise radiation exposure wherever possible. 
Our results also point to the significance of biological indicators, which provide information about the 
actual risk for the radiation-exposed individuals.
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Ionising radiation has become an important 
clinical tool for both medicinal diagnosis and therapy. 
Currently there are many radiopharmaceuticals 
in clinical use; ongoing research will undoubtedly 
result in an increase in the number of such agents 
(1). As the diagnostic and therapeutic applications 
of radiopharmaceuticals have continued to grow, 
the general public’s awareness of the hazards of 
ionising radiation has increased. The radioactivity 
administered presents a risk to the patient, which 
should be balanced against the benefit from obtaining 
a diagnosis or carrying out a treatment. Furthermore, 
contact with radioactive tissue from the patient or 
exposure to radiation emitted from radioactivity 
retained by the patient presents a risk to hospital staff 
and to members of the public (2).
Occupational exposure in nuclear medicine 
departments is mainly related to low doses of particular 
ionising emissions from radioactive isotopes such as 
99mTc, 131I, 32P, 67Ga, 111In, 201Tl, 59Fe, 57Co, 51Cr, and 
192Ir (3-5). These radioisotopes have unstable nuclei, 
and dissipate excess energy by spontaneously emitting 
radiation in the form of gamma and other rays.
Unlike patients, medical staff are usually exposed 
to much lower doses, but for a longer period of time. 
All professional and technical staff in nuclear medical 
facilities are responsible for maintaining radiation 
exposure at ALARA (as low as reasonably achievable) 
levels. However, due to the ability of ionising radiation 
to induce cellular damage, there is some level of risk 
for the development of genetic damage after radiation 
exposure.
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18-20 April 2005
32
To implement proper radioprotection procedures 
and restrict hazards to human health, it is very 
important to estimate the absorbed doses in 
individuals occupationally exposed to ionising 
radiation (6). The extent of health hazards is difficult 
to assess. In order to obtain information about the 
distribution and extent of radiation exposure, different 
biological methods for dose assessment have been 
developed. These include the evaluation of DNA 
mutations, chromosomal aberrations, the induction 
of micronuclei and sister chromatid exchanges (7, 
8). The most fully developed biological indicators of 
ionising radiation exposure are unstable chromosomal 
aberrations (dicentrics in particular) that can be 
detected in samples of peripheral blood lymphocytes 
(9-11). This method usually complements data 
obtained by physical dosimetry and is routinely used 
whenever the individual dosimeter shows an exposure 
to penetrating radiation above its limit of detection. 
One of the advantages of cytogenetic dosimetry is 
that this biological dosimeter can be assessed at any 
moment, unlike physical dosimeters which are not 
always carried by a subject. Another advantage is that 
subjects under study cannot intentionally modify the 
biological dosimeter (6).
As reported earlier, different cytogenetic effects 
were observed in nuclear medicine workers. There 
are reports of significant increases in the level of 
chromosomal aberrations (3), in SCE frequencies, and 
in HFC (high frequency cells) percentages compared 
to control population (5).
The aim of this study was to provide data on the 
genetic hazards associated with occupational exposure 
to low doses of ionising radiation in Croatian nuclear 
medicine departments. Using the chromosome 
aberration analysis, we assessed the incidence of DNA 
damage in peripheral blood lymphocytes.
SUBJECTS AND METHODS
The population under study consisted of 120 
volunteer blood donors: 60 were employees of nuclear 
medicine departments and 60 were unexposed 
control subjects. All participating subjects gave 
informed consent and were healthy at the moment of 
blood sampling and interviews. Blood samples were 
collected and further manipulated in accordance with 
high standards of ethics.
The exposed group included 37 women and 23 
men employed in nuclear medicine departments of 
four Croatian hospitals and exposed to particulate 
emissions from different radionuclides (dominantly 
131I and 99mTc). The average age of the subjects was 
42.5 years (range: 26 years to 59 years). All exposed 
subjects completed a standardised questionnaire 
including personal data, working activities, type and 
duration of occupational exposure at the time of 
the study, and information on exposure to possible 
confounding factors (smoking habit, alcohol use, 
medication intake, hormonal contraception, viral 
diseases, recent vaccinations, presence of known 
inherited genetic disorders, chronic disease, family 
history of cancer, exposure to indoor/outdoor 
pollutants, sunlight exposure, and radio diagnostic 
examinations). Twenty exposed subjects were smokers 
(12 women and 8 men), and 40 were non-smokers 
(25 women and 15 men). At the time of the study, 
the exposed subjects worked at nuclear medicine 
departments equipped and licensed for work with 
radionuclides, in compliance with national legislation. 
In their departments, all radiopharmaceuticals were 
prepared and dispensed in one place. Moreover, 
different radiation reduction measures and devices 
were also implemented. Mean duration of their 
occupational exposure at the time of blood sampling 
was 15.8 years (range: 1 year to 39 years). The exposed 
subjects were categorised in five subgroups according 
to their occupations: physicians (12 subjects: seven 
men and five women), technicians (26 subjects: 11 
men and 15 women), engineers (eight subjects: five 
men and three women), nurses (seven women) and 
cleaners (7 women). During their work, all exposed 
subjects regularly wore personal dosimeters. Exposed 
technicians and nurses worked only in nuclear 
medicine departments and were not involved in other 
activities (e.g. working preparation and/or application 
of other drugs, including antineoplastic agents).
The control group consisted of 60 matched 
blood donors (37 women and 23 men). They were 
selected among healthy students and administrative 
staff. All of them came from the same geographical 
location, and their dietary habits were not appreciably 
different. The average age of the control subjects was 
41.8 (range: 25 years to 59 years). Twenty controls 
were smokers (12 women and 8 men), while 40 were 
non-smokers (26 women and 14 men). At least one 
year before the study, the control subjects were not 
subjected diagnostic or therapeutic procedures using 
ionising or non-ionising radiation, nor did they have 
contact with whatever sources of ionising radiation. In 
addition no control reported a history of occupational 
exposure to known genotoxic chemicals or of alcohol 
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abuse, medicine intake, inherited genetic disorders 
or chronic diseases for at least one year before the 
beginning of the study.
Peripheral blood samples were collected by 
venipuncture into heparinised tubes (BD vacutainer, 
Becton Dickinson, N.J., USA) on six different occasions 
over six months. Blood samples were always collected 
in the morning hours, between 9 and 10 a.m., on 
the last day of their workweek (a balanced collection 
design was used). Samples from both exposed and 
non-exposed individuals were handled in the same 
manner. After the collection, all blood samples were 
randomly coded, refrigerated at 4 °C, transported to 
the laboratory and processed.
The chromosome aberration test was performed in 
agreement with the current IPCH and IAEA guidelines 
(11, 12). Whole blood cultures were established 
by adding 0.5 mL heparinised whole blood into 
5 mL of RPMI 1640 medium (Chromosome kit P, 
Euroclone) containing 10 % foetal bovine serum, 
phytohaemagglutinin, heparin, glutamine, growth 
factors, and antibiotic gentamycin. Duplicate cultures 
per subject were set up and incubated at (37±1) °C 
for 48 h. To arrest dividing lymphocytes in metaphase, 
colchicine (0.004 %) was added 2 h prior to the 
harvest. Cultures were centrifuged at 1000 rpm for 10 
min, the supernatant was carefully removed, and the 
cells were resuspended in a hypotonic solution (0.075 
mol L-1 KCl) at 37 °C. After centrifugation for 5 min at 
1000 rpm, the cells were fixed with a freshly prepared 
fixative of ice cold methanol / glacial acetic acid (3:1, 
v/v). Fixation and centrifugation were repeated several 
times until the supernatants were clear. Cells were 
pelleted and resuspended in a minimal amount of 
fresh fixative to obtain a homogeneous suspension. 
The cell suspension was dropped onto microscope 
slides and left to air-dry. Slides were stained with 5 % 
Giemsa solution (Sigma). All slides were coded and 
scored blindly. Metaphase analysis was conducted by 
a well-trained and experienced observer. Two hundred 
metaphases per subject (100 metaphases from each 
parallel culture) were analysed for chromosomal 
aberrations. Structural chromosome aberrations were 
classified based on the number of sister chromatids 
and breakage events involved. Only metaphases 
containing 45 to 47 centromeres were analysed. 
The evaluation included total number and types of 
aberrations, as well as the percentage of aberrant 
cells per subject.
We used Statistica 5.0 package (StatSoft, Tulsa, 
USA) for statistical analysis. Multiple comparisons 
between groups were made using multifactor ANOVA. 
Post-hoc analysis of differences was done using 
the Scheffé test. The level of statistical significance 
was set at p<0.05. The correlations between 
confounding factors and the parameters studied 
were also determined using the Pearson’s correlation 
matrices.
RESULTS
Figures 1 and 2 show individual chromosome 
aberration frequencies (CA) recorded in peripheral 
blood lymphocytes of occupationally exposed 
and control subjects. Table 1 reports group mean 
Figure 1  Individual results of the analysis of structural chromosome aberrations (CA) in peripheral blood lymphocytes of nuclear medicine personnel. 
Subjects are numbered as follows: physicians (1-12), technologists (13-38), nurses (39-45), engineers (46-53), cleaners (54-60).
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frequencies of CA recorded among control and 
exposed subgroups. Mean frequencies of CA for 
the subgroups of exposed population are shown in 
Table 2.
In general, there was a statistically significant 
difference between the mean CA frequencies in the 
exposed medical personnel [(2.37±0.16) CA per 
200 cells] and control subjects [(0.85±0.09) CA per 
200 cells] (p<0.01, ANOVA). The total percentage 
of aberrant cells was also significantly higher in 
the exposed subjects (1.15±0.08) than in controls 
(0.23±0.06). The exposed subjects demonstrated 
noticeable inter-individual variations in aberration 
types. Control subjects, in contrast, had a more 
homogenous distribution of CA in their peripheral 
blood lymphocytes. An increased incidence of 
chromatid breaks was observed in the exposed 
subjects, with a mean frequency of (1.40±0.30) 
per 200 cells, while controls had (0.55±0.08) 
chromatid breaks per 200 cells. The mean frequency 
of chromosome breaks in the exposed subjects 
was (0.33±0.07) per 200 cells, while controls had 
Figure 2  Individual results of the analysis of structural chromosome aberrations (CA) in peripheral blood lymphocytes of the control subjects.
Table 1  Incidence of structural chromosome aberrations (CA) in peripheral blood lymphocytes of nuclear medicine personnel and control 
subjects.
Subgroup Ȉ Ȉ CA Cells with CA / %










Women 37 2.41±0.21 1.16±0.10 1.41±0.17 0.30±0.09 0.68±0.12 0.03±0.03
Men 23 2.30±0.24 1.13±0.12 1.39±0.22 0.39±0.14 0.48±0.12 0.04±0.04
Non-smokers 40 2.45±0.21 1.19±0.10 1.38±0.17 0.38±0.10 0.68±0.12 0.03 ±0.03
Smokers 20 2.20±0.21 1.08±0.11 1.45±0.22 0.25±0.10 0.45±0.11 0.05 ±0 .05
Mean±SE 2.37± 0.16Ĺ 1.15±0.08Ĺ 1.40± 0.30Ĺ 0.33±0.07Ĺ 0.60±0.09Ĺ 0.03± 0.02Ĺ
CONTROL GROUP
Women 37 0.81±0.11 0.39±0.06 0.54±0.09 0.08±0.05 0.19±0.07 -
Men 23 0.91±0.18 0.48±0.06 0.57±0.15 0.04±0.04 0.30±0.10 -
Non-smokers 40 0.68±0.10 0.36±0.05 0.45±0.09 0.05±0.03 0.18±0.06 -
Smokers 20 1.20±0.19* 0.55±0.10 0.75±0.16 0.10±0.07 0.35±0.11 -
Mean±SE 0.85±0.09 0.43±0.05 0.55± 0.08 0.07± 0.03 0.23±0.06 -
Ĺ significantly increased compared to control subjects; * significantly increased compared to non-smokers; p<0.01 (multifactor ANOVA, post-hoc 
Scheffé test).
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(0.07±0.03) chromosome breaks per 200 cells. The 
mean yield of acentric fragments was (0.60±0.09) per 
200 cells in the exposed subjects and (0.23±0.06) in 
controls. No dicentric chromosomes were found in 
the lymphocytes of control subjects. The mean yield 
of dicentric chromosomes in the exposed group was 
(0.03±0.02) per 200 cells, that is, they were found 
only in two exposed technicians. The frequencies of 
chromosome aberrations were clearly elevated in 
all exposed subjects. All categories of aberrations 
were found, but without significant interaction 
between aberration type, sex, age and smoking 
habits. No statistically significant differences in the 
mean frequencies of chromosome aberrations were 
recorded between different occupations. Furthermore, 
no correlation was found between occupations, the 
time of exposure, whole-body radiation exposure, 
and the frequency of CA in individual cases. However, 
among controls there were significant differences in 
the total number of CA recorded between smokers 
[(1.20±0.19) CA per 200 cells] and non-smokers 
[(0.68±0.10) CA per 200 cells] (Table 1).
DISCUSSION
In this study we used a well-established biomarker 
of effect - chromosome aberration analysis - to 
evaluate the DNA damage in peripheral blood 
lymphocytes of nuclear medicine workers. As the 
results indicate, long-term occupational exposure to 
low doses of ionising radiation in nuclear medicine 
departments is associated with genotoxic effects.
Nuclear medicine staff work almost exclusively with 
J- and X-ray photons, ranging in energy from about 
60 keV to 700 keV. This energy is sufficient to produce 
ionisation events and break molecular bonds. If this 
energy is deposited in the intracellular fluid, toxic 
compounds may be formed that can be detrimental 
to cell survival (damage by indirect action). A photon 
could also directly impact cellular DNA, causing strand 
breaks (damage by direct action.). At low doses, the 
body's natural repair mechanisms usually perfectly 
repair any damage incurred (13). Many of induced 
DNA lesions are successfully repaired from a few 
minutes (4 min to 15 min) (14) to a couple of hours 
(2 h to 3 h) (15) after exposure. If the base damage 
is close between the opposite DNA strands (<10 bp 
apart), a simultaneous excision of such modified bases 
can lead to the formation of a double-strand break 
(DSB), which is believed to be the initial lesion in the 
formation of chromosome aberrations. Chromosome 
and chromatid breaks arise from DSBs that have 
been incompletely repaired or unrepaired. The repair 
of DSBs can also produce double fragments, giving 
rise to polycentric chromosomes or centric ring 
chromosomes (16) which are visible on metaphase 
preparations.
Chromosome aberrations are a sensitive 
bioindicator reflecting individual radiation damage 
and radiosensitivity. In our study most chromosome 
aberrations detected in peripheral blood lymphocytes 
of the exposed and control population were of 
chromatid-type. Furthermore, nuclear medicine 
workers had a significantly higher incidence of 
chromosome breaks (over four times) than unexposed 
controls. These results are in good agreement 
with earlier observations, and point to the effects 
of radiation exposure. Similarly to the results 
reported by Hagelström et al. (3) our study showed 







Ȉ CA Cells with 
CA / %












Nurses 8 64 0-270 2.71±0.29 1.29±0.10 1.57±0.30 0.43±0.20 0.71±0.29 -
Engineers 7 149 0-360 2.50±0.53 1.25±0.27 1.50±0.46 0.38±0.26 0.63±0.18 -
Cleaners 7 217 0-1020 2.43±0.43 1.21±0.21 1.43±0.37 0.29±0.18 0.71±0.36 -
Technologists 26 305 0-1401 2.27±0.26 1.08±0.12 1.27±0.20 0.38±0.12 0.54±0.13 0.08±0.05
Physicians 12 56 0-500 2.25±0.35 1.13±0.18 1.50±0.31 0.17± 0.11 0.58±0.19 -
Mean±SE 2.37±0.16 1.15±0.08 1.40±0.30 0.33±0.07 0.60±0.09 0.03± 0.02
* effective dose recorded on personal dosimeter one month prior to the study 
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neither complex chromosomal aberrations nor ring 
chromosomes, while dicentric chromosomes were 
found only in two exposed subjects. It is important 
to note that dicentrics and ring figures are unstable 
chromosome aberrations generally observed as the 
consequence of an in vitro or an acute in vivo ionising 
irradiation (3, 9). Low yields of dicentrics and no rings 
recorded in our study were probably due to the low 
level of ionising radiation chronically received. It is 
also possible that most exposed subjects in our study 
followed the radiation safety guidelines and used 
protective devices at work. Long-term occupational 
exposure to radiation is related to the induction of 
stable balanced translocations in peripheral blood 
lymphocytes (17). However, this possibility has to be 
studied on the same population in future using the 
chromosome painting techniques.
The exposed population demonstrated great 
inter-individual heterogeneity in DNA damage, 
especially where there was no relationship between 
the extent of exposure, doses received and the levels 
of DNA damage recorded. This observation raises 
the general question of the relationship between the 
induction of DNA damage in resting lymphocytes, 
and its subsequent fixation in genetic alterations 
after stimulation. We assume that most DNA damage 
induced in vivo in circulating lymphocytes is repaired, 
thus escaping fixation, as was also reported in other 
studies (18, 19).
Heterogeneity in DNA damage recorded in the 
exposed subjects could also be attributed to other 
confounding factors including specific modes 
of exposure, different radiation doses received, 
differences in individual genome sensitivity, various 
lifestyle-associated factors, as well as to compliance 
with radiation safety guidelines during everyday work. 
Because specialised workers often tend to perform 
the same tasks, it is quite possible that some of 
them would sustain higher levels of DNA damage. 
Therefore, it is likely that subjects with high levels of 
DNA damage were involved in specific procedures 
associated with higher exposure.
In our study, DNA damage recorded was not in 
positive correlation with the effective dose recorded. 
Other authors also argue that it is difficult to establish 
a dose-effect relationship for low doses of radiation 
(20, 21). Today, the recommended maximum annual 
occupational dose limit is 50 mSv (10, 13). However, 
with current regulatory safeguards in place, it is rare 
that a radiation worker exceeds this dose.
For X- or J-rays, good evidence of an increase in 
risk for cancer is shown at acute doses >50 mSv and 
reasonable evidence is given of an increase in some 
cancer risks at subacute doses above 5 mSv (22). At 
doses much higher than 0.5 Gy, radiation exposure 
is clearly a known carcinogen, primarily due to its 
mutagenic effects on cells. However, it is difficult to say 
that any cancer is solely caused by radiation exposure, 
as cancer may be caused by a combination of factors 
(23). Given our current state of knowledge, the most 
reasonable assumption is that the cancer risks from 
low doses of X- or J-rays decrease with dose (22). 
Doses recorded among the exposed subjects one 
year before our study began (data not shown) were 
well below the maximum annual occupational dose 
limit. One month before blood sampling, these doses 
were mostly in the range of Sv, not mSv.
Generally speaking, exposure to ionising radiation 
may produce both deterministic and stochastic 
effects. Radiation workers run greater risk of 
deterministic effects only if they fail to observe 
hospital safety policies and procedures. Cancer and 
genetic mutations are the examples of stochastic 
effects caused by occupational exposure to ionising 
radiation. These are long term effects, which do not 
show in the exposed population until many years after 
the exposure. The exact risk of radiation-induced 
cancer at very low doses is not totally understood 
and is further complicated by many factors, such as 
the magnitude of the dose, the time span over which 
the dose was delivered, the general state of the health 
of the individual, the type of radiation to which the 
individual was exposed, the energy of the radiation and 
the area of the body to which the dose was delivered, 
among others (13).
In conclusion, it is important to realise that 
radiation exposure, environmental or occupational 
alike, is not the only risk factor in our lives, nor it is the 
most prominent. Our study indicates the possibility of 
genotoxic implications in nuclear medicine personnel 
occupationally exposed to low doses of ionising 
radiation for an extended period. To avoid possible 
genotoxic effects, the exposed medical personnel 
should carefully apply radiation protection procedures 
and should minimize occupational radiation exposure. 
Our results also confirm that chromosome aberrations 
are important biological indicators and sensitive 
predictors of the actual risk run by radiation-exposed 
individuals. This is especially true for the distribution 
and the extent of radiation exposure, as these data are 
seldom provided by physical dosimetry.
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Sažetak
PROCJENA CITOGENETIÈKIH OŠTEÆENJA U MEDICINSKOG OSOBLJA PROFESIONALNO 
IZLOŽENOG NISKIM DOZAMA IONIZIRAJUÆEG ZRAÈENJA NA ODJELIMA NUKLEARNE 
MEDICINE
Ionizirajuæe zraèenje izaziva razlièita ošteæenja u živim stanicama, èija je pojava ovisna o dozi kojoj su stanice 
izložene, apsorbiranoj dozi, trajanju izloženosti te osjetljivosti tkiva. Osoblje profesionalno izloženo zraèenju 
pod poveæanim je rizikom od štetnih uèinaka ionizirajuæeg zraèenja samo u sluèajevima nepoštivanja 
propisa sigurnosti pri radu. Dugogodišnja profesionalna izloženost zraèenju za posljedicu može imati 
zloæudne bolesti (rak) i genske mutacije. Unatoè intenzivnim istraživanjima, genetska ošteæenja proizašla 
iz izloženosti osoblja ionizirajuæem zraèenju još nisu potpuno razjašnjena, a posebice ona proizašla iz 
izloženosti niskim dozama. Cilj ovog istraživanja bio je prouèiti genetska ošteæenja nastala pod utjecajem 
profesionalne izloženosti niskim dozama ionizirajuæeg zraèenja u osoblja zaposlenog na odjelima nuklearne 
medicine. Procjena ošteæenja DNA u limfocitima periferne krvi izloženoga medicinskog osoblja provedena 
je s pomoæu testa analize kromosomskih aberacija. Istraživanje je obuhvatilo ukupno 120 ispitanika 
(60 izloženih i 60 kontrolnih). U izloženih ispitanika utvrðena je statistièki znaèajno povišena uèestalost 
kromosomskih aberacija u usporedbi s kontrolnom skupinom. Unutar izložene skupine uoèene su i znaèajne 
interindividualne razlike u razini ošteæenja DNA, koje upuæuju na razlièitu genetsku osjetljivost. Dob i spol 
ispitanika nisu znaèajnije utjecali na razinu ošteæenja genoma, a navika pušenja utjecala je na porast razine 
ošteæenja DNA samo u ispitanika kontrolne skupine. Na osnovi dobivenih rezultata vidljivo je da kronièna 
profesionalna izloženost niskim dozama ionizirajuæeg zraèenja na odjelima nuklearne medicine izaziva 
genotoksièna ošteæenja u limfocitima periferne krvi medicinskog osoblja. Kako bi se izbjegli potencijalni 
genotoksièni uèinci, izloženost medicinskog osoblja, kad god je to moguæe, treba smanjiti na najmanju 
moguæu razinu. Dobiveni rezultati takoðer naglašavaju važnost primjene bioloških indikatora koji pružaju 
niz informacija o stvarnom i trenutaènom riziku za izložene ispitanike koji se ne mogu dobiti iz fizikalne 
dozimetrije.
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